Stay updated on Pembrolizumab in Recurrent Gastric Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in Recurrent Gastric Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in Recurrent Gastric Cancer Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.4.3, replacing the previous Revision: v3.4.2.
    Difference
    0.0%
    Check dated 2026-03-11T14:25:59.000Z thumbnail image
  2. Check
    10 days ago
    No Change Detected
  3. Check
    18 days ago
    No Change Detected
  4. Check
    25 days ago
    Change Detected
    Summary
    Gastric cancer is added as a related topic and the Genetic and Rare Diseases Information Center is added as a resources entry for gastric cancer.
    Difference
    0.1%
    Check dated 2026-02-18T07:29:07.000Z thumbnail image
  5. Check
    32 days ago
    Change Detected
    Summary
    Added a new site revision label: Revision: v3.4.2. The government funding lapse notice and the earlier Revision: v3.4.1 entry were removed.
    Difference
    0.4%
    Check dated 2026-02-11T05:37:29.000Z thumbnail image
  6. Check
    39 days ago
    Change Detected
    Summary
    Added a site-wide government funding lapse notice and updated the page revision from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-04T05:31:11.000Z thumbnail image
  7. Check
    46 days ago
    Change Detected
    Summary
    Show glossary toggle (Show glossary) was added to the page. Minor textual updates include capitalization changes to QC-related labels and the revision tag updated to v3.4.0.
    Difference
    0.2%
    Check dated 2026-01-28T03:14:20.000Z thumbnail image
  8. Check
    53 days ago
    Change Detected
    Summary
    Sponsor information and links to key documents and IPD data-sharing resources were removed, including the Study Protocol, Statistical Analysis Plan, and IPD Sharing Url/Plan Description. A broad set of metadata and keywords describing the trial were also deleted.
    Difference
    20%
    Check dated 2026-01-21T01:21:13.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in Recurrent Gastric Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Recurrent Gastric Cancer Clinical Trial page.